Stock listing
A3D8QG Stock Price, News, Filings & Events — Oculis Holding Ag
Selected listing: A3D8QG · LS · EUR · DE
This page tracks Oculis Holding Ag's A3D8QG:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3D8QG:LS. A3D8QG:LS is the stock-level entry point for investors researching Oculis Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3D8QG:LS
- Asset type
- Stock
- Market cap
- $650.4M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- LS
- Currency
- EUR
Oculis Holding Ag A3D8QG:LS stock context
This page tracks Oculis Holding Ag's A3D8QG:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3D8QG:LS. A3D8QG:LS is the stock-level entry point for investors researching Oculis Holding Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Oculis Holding Ag
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
August 24, 2026
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emergin...
August 10, 2026
Oculis Reports Q2 2026 Financial Results and Provides Company Update
August 6, 2026
Oculis Announces Positive FDA Pre-IND Feedback Supporting Privosegtor Development Strategy for Treatment of Acute Multiple Sclerosis Rela...
August 3, 2026
Oculis to Participate at the Piper Sandler Virtual Ophthalmology Conference
July 2, 2026
Research Oculis Holding Ag
Oculis Holding Ag investor report
Review AI stock analysis and investor report context for A3D8QG:LS.
Oculis Holding Ag company profile
View the public company page for Oculis Holding Ag on 6ix.
Oculis Holding Ag news
Read company news and market updates connected to Oculis Holding Ag.
Oculis Holding Ag investor events
Find investor webinars, events, and replay context for Oculis Holding Ag.
Alternate listings
OCS:NASDAQ
US · USD
Alternate listing for Oculis Holding Ag; the primary context on this page is A3D8QG:LS.
OCS:OMXICE
IS · ISK
Alternate listing for Oculis Holding Ag; the primary context on this page is A3D8QG:LS.
A3D8QG:LSX
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is A3D8QG:LS.
CR5:SWB
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is A3D8QG:LS.
CR5:FWB
DE · EUR
Alternate listing for Oculis Holding Ag; the primary context on this page is A3D8QG:LS.
OCS:BOATS
US · USD
Alternate listing for Oculis Holding Ag; the primary context on this page is A3D8QG:LS.